BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC, Lassalle P. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 2010;56:180-187. [PMID: 20102396 DOI: 10.1111/j.1365-2559.2009.03458.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Laloglu E, Kumtepe Y, Aksoy H, Topdagi Yilmaz EP. Serum endocan levels in endometrial and ovarian cancers. J Clin Lab Anal 2017;31. [PMID: 27734523 DOI: 10.1002/jcla.22079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
2 Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L. Prognostic value of endocan expression in cancers: evidence from meta-analysis. Onco Targets Ther 2016;9:6297-304. [PMID: 27785077 DOI: 10.2147/OTT.S110295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Palmiere C, Augsburger M. Markers for sepsis diagnosis in the forensic setting: state of the art. Croat Med J 2014;55:103-14. [PMID: 24778096 DOI: 10.3325/cmj.2014.55.103] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
4 Kim KH, Lee HH, Yoon YE, Na JC, Kim KS, Han WK. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker. Investig Clin Urol 2019;60:425-31. [PMID: 31692952 DOI: 10.4111/icu.2019.60.6.425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Yuksel MA, Tuten A, Oncul M, Acikgoz AS, Temel Yuksel I, Toprak MS, Ekmekci H, Balci Ekmekci O, Madazli R. Serum endocan concentration in women with pre-eclampsia. Arch Gynecol Obstet 2015;292:69-73. [PMID: 25534164 DOI: 10.1007/s00404-014-3605-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
6 Palmiere C, Augsburger M. Endocan measurement for the postmortem diagnosis of sepsis. Legal Medicine 2014;16:1-7. [DOI: 10.1016/j.legalmed.2013.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gungor A, Palabiyik SS, Bayraktutan Z, Dursun H, Gokkaya N, Bilen A, Bilen H. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim. Endocrine Research 2016;41:275-80. [DOI: 10.3109/07435800.2015.1135443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maiti A, Okano I, Oshi M, Okano M, Tian W, Kawaguchi T, Katsuta E, Takabe K, Yan L, Patnaik S, Hait NC. Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs. Cancers (Basel) 2021;13:2641. [PMID: 34072157 DOI: 10.3390/cancers13112641] [Reference Citation Analysis]
9 Zhang S, Zuo L, Zhou Q, Gui S, Shi R, Wu Q, Wei W, Wang Y. Expression and distribution of endocan in human tissues. Biotechnic & Histochemistry 2012;87:172-8. [DOI: 10.3109/10520295.2011.577754] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
10 Yang WE, Hsieh MJ, Lin CW, Kuo CY, Yang SF, Chuang CY, Chen MK. Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression. Int J Med Sci 2017;14:1094-100. [PMID: 29104463 DOI: 10.7150/ijms.20414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
11 Li S, Wang L, Wang C, Wang Q, Yang H, Liang P, Jin F. Detection on Dynamic Changes of Endothelial Cell Specific Molecule–1 in Acute Rejection After Renal Transplantation. Urology 2012;80:738.e1-8. [DOI: 10.1016/j.urology.2012.03.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
12 Sarrazin S, Lyon M, Deakin JA, Guerrini M, Lassalle P, Delehedde M, Lortat-jacob H. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. Glycobiology 2010;20:1380-8. [DOI: 10.1093/glycob/cwq100] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
13 Laloglu E, Aksoy H, Aksoy Y, Ozkaya F, Akcay F. The determination of serum and urinary endocan concentrations in patients with bladder cancer. Ann Clin Biochem 2016;53:647-53. [PMID: 26748103 DOI: 10.1177/0004563216629169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang S, Wu Z, Wei L, Zhang J. Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma. BMC Endocr Disord 2019;19:90. [PMID: 31455321 DOI: 10.1186/s12902-019-0418-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Kuluöztürk M, İn E, İlhan N. Endocan as a marker of disease severity in pulmonary thromboembolism. Clin Respir J 2019;13:773-80. [PMID: 31556240 DOI: 10.1111/crj.13089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M. Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer. 2014;5:221-230. [PMID: 24665346 DOI: 10.7150/jca.7691] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
17 Whayne TF. Endocan in Hypertension and Cardiovascular Disease. Angiology 2014;65:757-9. [DOI: 10.1177/0003319713514478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Abu El-asrar AM, Nawaz MI, De Hertogh G, Al-kharashi AS, Van den Eynde K, Mohammad G, Geboes K. The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor. Current Eye Research 2014;40:321-31. [DOI: 10.3109/02713683.2014.921312] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wu X, Wu Y, He L, Wu L, Wang X, Liu Z. Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J Cancer 2018;9:2510-7. [PMID: 30026849 DOI: 10.7150/jca.25324] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 18.0] [Reference Citation Analysis]
20 Chang Y, Niu W, Lian PL, Wang XQ, Meng ZX, Liu Y, Zhao R. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer. World J Gastroenterol 2016; 22(23): 5422-5429 [PMID: 27340359 DOI: 10.3748/wjg.v22.i23.5422] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
21 Gu Y, Zou YM, Lei D, Huang Y, Li W, Mo Z, Hu Y. Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma. Sci Rep 2017;7:14200. [PMID: 29079774 DOI: 10.1038/s41598-017-14314-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
22 Seo K, Kitazawa T, Yoshino Y, Koga I, Ota Y. Characteristics of serum endocan levels in infection. PLoS One 2015;10:e0123358. [PMID: 25894539 DOI: 10.1371/journal.pone.0123358] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
23 Kim KH, Lee HH, Yoon YE, Na JC, Kim SY, Cho YI, Hong SJ, Han WK. Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma. Oncotarget 2018;9:662-7. [PMID: 29416643 DOI: 10.18632/oncotarget.23087] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sagara A, Igarashi K, Otsuka M, Kodama A, Yamashita M, Sugiura R, Karasawa T, Arakawa K, Narita M, Kuzumaki N, Narita M, Kato Y. Endocan as a prognostic biomarker of triple-negative breast cancer. Breast Cancer Res Treat 2017;161:269-78. [PMID: 27888420 DOI: 10.1007/s10549-016-4057-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
25 Iwahashi S, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T, Takasu C, Saito Y, Yamada S. Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation. Cancer Lett 2016;375:47-50. [PMID: 26940140 DOI: 10.1016/j.canlet.2016.02.041] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
26 Alici Davutoglu E, Akkaya Firat A, Ozel A, Uzun I, Özer N, Madazli R. The utility of maternal serum endocan level to predict preterm delivery within seven days in patients with threatened preterm labor. J Matern Fetal Neonatal Med 2021;34:1786-91. [PMID: 31434521 DOI: 10.1080/14767058.2019.1649388] [Reference Citation Analysis]
27 Lin LY, Yeh YC, Chu CH, Won JGS, Shyr YM, Chao Y, Li CP, Wang SE, Chen MH. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors. Medicine (Baltimore) 2017;96:e8262. [PMID: 29019897 DOI: 10.1097/MD.0000000000008262] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
28 Dong R, Jia D, Xue P, Cui X, Li K, Zheng S, He X, Dong K. Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues. PLoS One 2014;9:e85599. [PMID: 24465615 DOI: 10.1371/journal.pone.0085599] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
29 Feng R, Li Z, Wang X, Ge G, Jia Y, Wu D, Ji Y, Wang C. Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis. Cancer Cell Int 2021;21:67. [PMID: 33482820 DOI: 10.1186/s12935-020-01717-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang S, Zuo L, Gui S, Zhou Q, Wei W, Wang Y. Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol Biol Rep 2012;39:2843-9. [PMID: 21678055 DOI: 10.1007/s11033-011-1043-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
31 Arslan B, Onuk Ö, Hazar İ, Aydın M, Çilesiz NC, Eroglu A, Nuhoglu B. Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy. Tumori 2017;103:204-8. [DOI: 10.5301/tj.5000535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Sumei Z, Shaolong C, Xiang W, Yinliang Q, Qing Z, Yuan W. Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression. Tumour Biol 2016;37:14915-21. [PMID: 27644250 DOI: 10.1007/s13277-016-5398-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Celik ZE, Demir F, Yonar H, Ugras S. Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma. Cancer Biomark 2021. [PMID: 34151832 DOI: 10.3233/CBM-201026] [Reference Citation Analysis]
34 Yu PH, Chou SF, Chen CL, Hung H, Lai CY, Yang PM, Jeng YM, Liaw SF, Kuo HH, Hsu HC, Chen JY, Wang WB. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma. PLoS One 2013;8:e82254. [PMID: 24340011 DOI: 10.1371/journal.pone.0082254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
35 Pan KF, Lee WJ, Chou CC, Yang YC, Chang YC, Chien MH, Hsiao M, Hua KT. Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer. EMBO J 2021;40:e105450. [PMID: 33347625 DOI: 10.15252/embj.2020105450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zuo L, Lu M, Zhou Q, Wei W, Wang Y. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food and Chemical Toxicology 2013;62:892-900. [DOI: 10.1016/j.fct.2013.10.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
37 Xu L, Tang L, Zhang L. Proteoglycans as miscommunication biomarkers for cancer diagnosis. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Elsevier; 2019. pp. 59-92. [DOI: 10.1016/bs.pmbts.2018.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
38 Yang J, Sheng S, Yang Q, Li L, Qin S, Yu S, Zhang X. Endocan silencing induces programmed cell death in hepatocarcinoma. Oncol Lett 2017;14:5333-9. [PMID: 29113167 DOI: 10.3892/ol.2017.6857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
39 Descloux E, Augsburger M, Teresiński G, Hejna P, Grouzmann E, Scarpelli MP, Hervet T, Palmiere C. Endocan concentrations in postmortem serum, vitreous humor and urine in victims of lethal hypothermia. Journal of Forensic and Legal Medicine 2017;50:39-43. [DOI: 10.1016/j.jflm.2017.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Depontieu F, de Freitas Caires N, Gourcerol D, Giordano J, Grigoriu B, Delehedde M, Lassalle P. Development of monoclonal antibodies and ELISA specific for the mouse vascular endocan. J Immunol Methods 2012;378:88-94. [PMID: 22370430 DOI: 10.1016/j.jim.2012.02.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
41 Buczek M, Escudier B, Bartnik E, Szczylik C, Czarnecka A. Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms. Biochim Biophys Acta 2014;1845:31-41. [PMID: 24135488 DOI: 10.1016/j.bbcan.2013.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 45] [Article Influence: 2.1] [Reference Citation Analysis]
42 Bicer M, Guler A, Unal Kocabas G, Imamoglu C, Baloglu A, Bilgir O, Yuksel A, Bozkaya G, Calan M. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Endocr Res 2017;42:145-53. [PMID: 27911121 DOI: 10.1080/07435800.2016.1255896] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
43 Hung TW, Chu CY, Yu CL, Lee CC, Hsu LS, Chen YS, Hsieh YH, Tsai JP. Endothelial Cell-Specific Molecule 1 Promotes Endothelial to Mesenchymal Transition in Renal Fibrosis. Toxins (Basel) 2020;12:E506. [PMID: 32781625 DOI: 10.3390/toxins12080506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Bălănescu P, Lădaru A, Bălănescu E, Voiosu T, Băicuş C, Dan GA. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study. J Clin Lab Anal 2016;30:368-73. [PMID: 26331941 DOI: 10.1002/jcla.21864] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
45 Yang J, Yang Q, Yu S, Zhang X. Endocan: A new marker for cancer and a target for cancer therapy. Biomed Rep 2015;3:279-83. [PMID: 26137222 DOI: 10.3892/br.2015.438] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
46 Güzel A, Duran L, Köksal N, Torun AC, Alaçam H, Ekiz BC, Murat N. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism. Blood Coagul Fibrinolysis 2014;25:272-6. [PMID: 24509328 DOI: 10.1097/MBC.0000000000000071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zhang H, Shen YW, Zhang LJ, Chen JJ, Bian HT, Gu WJ, Zhang H, Chen HZ, Zhang WD, Luan X. Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach. Front Oncol 2021;11:687120. [PMID: 34109132 DOI: 10.3389/fonc.2021.687120] [Reference Citation Analysis]
48 Rocha SF, Schiller M, Jing D, Li H, Butz S, Vestweber D, Biljes D, Drexler HC, Nieminen-kelhä M, Vajkoczy P, Adams S, Benedito R, Adams RH. Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability. Circ Res 2014;115:581-90. [DOI: 10.1161/circresaha.115.304718] [Cited by in Crossref: 86] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
49 Lv Z, Fan Y, Chen H, Zhao D. Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer. Tumour Biol 2014;35:10497-502. [PMID: 25056533 DOI: 10.1007/s13277-014-2319-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
50 Xing Y, Wang Y, Wang S, Wang X, Fan D, Zhou D, An J. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression. Transl Res 2016;177:113-26. [PMID: 27474433 DOI: 10.1016/j.trsl.2016.06.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
51 Lai CY, Chen CM, Hsu WH, Hsieh YH, Liu CJ. Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma. Int J Med Sci 2017;14:1263-7. [PMID: 29104483 DOI: 10.7150/ijms.21023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
52 Miao Y, Zong M, Jiang T, Yuan X, Guan S, Wang Y, Zhou D. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion. Pituitary 2016;19:194-201. [PMID: 26809958 DOI: 10.1007/s11102-015-0698-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
53 Chew BS, Ghazali R, Othman H, Ismail NAM, Othman AS, Laim NMST, Wong YP, Tan GC. Endocan expression in placenta of women with hypertension. J Obstet Gynaecol Res 2019;45:345-51. [PMID: 30306675 DOI: 10.1111/jog.13836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
54 Kechagia M, Papassotiriou I, Gourgoulianis KI. Endocan and the respiratory system: a review. Int J Chron Obstruct Pulmon Dis 2016;11:3179-87. [PMID: 28003744 DOI: 10.2147/COPD.S118692] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
55 Chen C, Shin JH, Eggold JT, Chung MK, Zhang LH, Lee J, Sunwoo JB. ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma. Oncotarget 2016;7:70738-49. [PMID: 27683113 DOI: 10.18632/oncotarget.12210] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
56 Lee YH, Kim SY, Moon H, Seo JW, Kim DJ, Park SH, Kim YG, Moon JY, Kim JS, Jeong KH, Lim SJ, Kim CD, Park JB, Chung BH, Kim YH, Yang J, Yang HI, Kim KS, Lee SH. Endocan as a marker of microvascular inflammation in kidney transplant recipients. Sci Rep 2019;9:1854. [PMID: 30755622 DOI: 10.1038/s41598-018-37975-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
57 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
58 Ozalper V, Kara M, Tanoglu A, Cetındaglı I, Ozturker C, Hancerlı Y, Hıra S, Kara K, Beyazıt Y, Yazgan Y. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Rheumatol 2017;36:2071-7. [PMID: 28074304 DOI: 10.1007/s10067-016-3532-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
59 Pan KF, Yang YC, Lee WJ, Hua KT, Chien MH. Proteoglycan Endocan: A multifaceted therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188672. [PMID: 34953930 DOI: 10.1016/j.bbcan.2021.188672] [Reference Citation Analysis]
60 Lu GJ, Shao CJ, Zhang Y, Wei YY, Xie WP, Kong H. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer. Oncotarget 2017;8:49217-23. [PMID: 28514746 DOI: 10.18632/oncotarget.17455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
61 Wang G, Yu Y, Wang YZ, Wang JJ, Guan R, Sun Y, Shi F, Gao J, Fu XL. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. J Cell Physiol 2019;234:17023-49. [PMID: 30888065 DOI: 10.1002/jcp.28436] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 11.7] [Reference Citation Analysis]
62 Li C, Geng H, Ji L, Ma X, Yin Q, Xiong H. ESM-1: A Novel Tumor Biomaker and its Research Advances. ACAMC 2019;19:1687-94. [DOI: 10.2174/1871520619666190705151542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
63 Cai L, Leng ZG, Guo YH, Lin SJ, Wu ZR, Su ZP, Lu JL, Wei LF, Zhuge QC, Jin K, Wu ZB. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine 2016;52:641-51. [PMID: 26662185 DOI: 10.1007/s12020-015-0824-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
64 Xu H, Chen X, Huang Z. Identification of ESM1 overexpressed in head and neck squamous cell carcinoma. Cancer Cell Int 2019;19:118. [PMID: 31073279 DOI: 10.1186/s12935-019-0833-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
65 Yoon KH, Kim SY, Moon YS, Roh D, Lee SK, Kim DH. The Relationship between Serum Endocan Levels and Depression in Alzheimer's Disease. Dis Markers 2016;2016:8254675. [PMID: 26924874 DOI: 10.1155/2016/8254675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
66 Liu N, Zhang LH, Du H, Hu Y, Zhang GG, Wang XH, Li JY, Ji JF. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. Ann Surg Oncol. 2010;17:2628-2639. [PMID: 20383661 DOI: 10.1245/s10434-010-1037-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
67 Kano K, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Maezawa Y, Aoyama T, Fujikawa H, Hiroshima Y, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy. In Vivo 2020;34:461-7. [PMID: 31882514 DOI: 10.21873/invivo.11796] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bingol Z, Kose M, Pıhtılı A, Akpınar T, Tukek T, Kıyan E. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea. Biomarkers in Medicine 2016;10:177-84. [DOI: 10.2217/bmm.15.117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
69 Bettin A, Reyes I, Reyes N. Gene Expression Profiling of Prostate Cancer–Associated Genes Identifies Fibromodulin as Potential Novel Biomarker for Prostate Cancer. Int J Biol Markers 2016;31:153-62. [DOI: 10.5301/jbm.5000184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
70 Rathnasamy G, Sivakumar V, Foulds WS, Ling EA, Kaur C. Vascular changes in the developing rat retina in response to hypoxia. Exp Eye Res 2015;130:73-86. [PMID: 25433125 DOI: 10.1016/j.exer.2014.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
71 Qiu C, Fu Q, Sui J, Zhang Q, Wei P, Wu Y, Zhu K, Lu Y, Zong B. Serum Endothelial Cell–Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance: A Pilot Study. Angiology 2017;68:354-9. [DOI: 10.1177/0003319716651349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
72 Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc J, Sturm N, Bioulac-sage P, Nahon P, Nault J, Charnaux N, N’kontchou G, Trinchet J, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-carrié N. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. Journal of Hepatology 2013;59:1264-70. [DOI: 10.1016/j.jhep.2013.07.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
73 Bessa J, Albino-Teixeira A, Reina-Couto M, Sousa T. Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. Clin Chim Acta 2020;509:310-35. [PMID: 32710940 DOI: 10.1016/j.cca.2020.07.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Jin H, Rugira T, Ko YS, Park SW, Yun SP, Kim HJ. ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells. Cancers (Basel) 2020;12:E1363. [PMID: 32466580 DOI: 10.3390/cancers12061363] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
75 Zhang Y, Wang J, Dong F, Li H, Hou Y. The effect of proteoglycans inhibited on the neurotropic growth of salivary adenoid cystic carcinoma: PG inhibited on the neurotropic growth of SACC. Journal of Oral Pathology & Medicine 2011;40:476-82. [DOI: 10.1111/j.1600-0714.2011.01024.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
76 Cornelius A, Cortet-Rudelli C, Assaker R, Kerdraon O, Gevaert MH, Prévot V, Lassalle P, Trouillas J, Delehedde M, Maurage CA. Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma. Brain Pathol. 2012;22:757-764. [PMID: 22353248 DOI: 10.1111/j.1750-3639.2012.00578.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
77 Li S, Liang P, Zhao Y, Li X, Hu Y, Wu W, Li Y, Zhou P, Wang Q, Yang W, Wang L, Wang Q, Yang H, Cheng W, Chao W, Zhang B, Jin F. Detection and mechanism of action of ESM-1 in rat kidney transplantation under various immune states. Cell Immunol 2013;283:31-7. [PMID: 23850961 DOI: 10.1016/j.cellimm.2013.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
78 Delehedde M, Devenyns L, Maurage CA, Vivès RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;2013:705027. [PMID: 23606845 DOI: 10.1155/2013/705027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
79 Zhao W, Sun M, Li S, Wang Y, Liu J. Biological and clinical implications of endocan in gastric cancer. Tumour Biol 2014;35:10043-9. [PMID: 25012244 DOI: 10.1007/s13277-014-2287-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]